文献速递急性肾损伤血液净化与透析

危重症患者的腹膜透析:是时候进行批判性重新评估了吗?

Peritoneal Dialysis in Critically Ill Patients: Time for a Critical Reevaluation?
PubMed 文献 · Clin J Am Soc Nephrol · 2022-01-13

本文综述腹膜透析(PD)在危重症患者中用于急性肾损伤(AKI)治疗及维持性PD继续使用的利弊、适应证与禁忌证。文章指出,尽管体外连续肾脏替代治疗普及导致高收入国家PD用于AKI减少,但低收入和中等收入国家的使用及COVID-19大流行期间资源受限时的经验重新引发兴趣。综述还讨论了PD通路建立、处方管理和并发症监测,并探讨在资源受限之外扩大PD用于AKI治疗的可能性。

要点

  • 腹膜透析(PD)曾广泛用于成人AKI治疗,但体外连续肾脏替代治疗的出现导致高收入国家使用下降。
  • 对危重症患者缺乏熟悉和把握也导致即使维持性PD患者也较少使用,许多重症监护单元在入院时反射性地转换为其他透析疗法。
  • COVID-19大流行期间资源受限时早期使用PD for AKI的经验重新引发兴趣。

核心结论

  • 本文综述危重症患者中腹膜透析(PD)用于AKI治疗及维持性PD继续使用的利弊、适应证和禁忌证,并探讨在资源受限之外扩大PD用于AKI治疗的可能性。

研究设计与样本

  • 本文为综述,检索范围未在原文中明确报告。

主要发现

  • PD作为成人AKI治疗在20世纪80年代前在重症监护中广泛接受。
  • 体外连续KRT的出现导致高收入国家PD用于AKI广泛下降。
  • 对危重症环境中使用PD缺乏熟悉和把握也导致即使接受维持性PD的患者也缺乏使用。
  • 许多重症监护单元在入院时反射性地将接受维持性PD的患者转换为替代透析疗法。
  • 由于在低收入和中等收入国家使用增加,对PD用于AKI治疗重新产生兴趣。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Peritoneal dialysis (PD) as an AKI treatment in adults was widely accepted in critical care settings well into the 1980s. The advent of extracorporeal continuous KRT led to widespread decline in the use of PD for AKI across high-income countries. The lack of familiarity and comfort with the use of PD in critical care settings has also led to lack of use even among those receiving maintenance PD. Many critical care units reflexively convert patients receiving maintenance PD to alternative dialysis therapies at admission. Renewed interest in the use of PD for AKI therapy has emerged due to its increasing use in low- and middle-income countries. In high-income countries, the coronavirus disease 2019 (COVID-19) pandemic, saw PD for AKI used early on, where many critical care units were in crisis and relied on PD use when resources for other AKI therapy modalities were limited. In this review, we highlight advantages and disadvantages of PD in critical care settings and indications and contraindications for its use. We provide an overview of literature to support both PD treatment during AKI and its continuation as a maintenance therapy during critical illness. For AKI therapy, we further discuss establishment of PD access, PD prescription management, and complication monitoring and treatment. Finally, we discuss expansion in the use of PD for AKI therapy extending beyond its role during times of resource constraints.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Al Sahlawi M, Ponce D, Charytan DM, et al. Peritoneal Dialysis in Critically Ill Patients: Time for a Critical Reevaluation? Clin J Am Soc Nephrol. 2022. PMID: 36754063. doi:10.2215/CJN.0000000000000059

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。